Press Releases
Richard Curtis releases new version of famous Al Pacino ‘locker room’ scene to mark that the world is at halftime on Sustainable Development Goals
Al Pacino still from ‘Inches (with Al Pacino)| The Global Goals | Halftime 2023’ The world is at ‘Halftime’ when it comes to achieving 2030 Sustainable Development Goals – but only 15% are on track to be met Richard Curtis
Richard Curtis lança nova versão da famosa cena do balneário de Al Pacino para salientar que o mundo está no “Intervalo” para alcançar os Objetivos de Desenvolvimento Sustentável
Al Pacino still from ‘Inches (with Al Pacino)| The Global Goals | Halftime 2023’ O mundo está no período de intervalo para alcançar os Objetivos de Desenvolvimento Sustentável até 2030 – mas apenas 15% deles estão a caminho de ser
Richard Curtis sort une nouvelle version de la célèbre scène des vestiaires avec Al Pacino pour marquer la mi-temps de l’échéance de réalisation des Objectifs de Développement Durable
Al Pacino still from ‘Inches (with Al Pacino)| The Global Goals | Halftime 2023’ Le monde est à la « mi-temps » de son échéance pour la réalisation des Objectifs de Développement Durable pour 2030, mais seuls 15 % de
Chief Sales Officer of AI-Media Excited to Showcase Subtitling Innovation at Upcoming IBC Broadcast Tradeshow
AI-Media Exhibits at IBC 2023 BROOKLYN, N.Y., Sept. 13, 2023 (GLOBE NEWSWIRE) — AI-Media, the leader in technology-driven live captioning & subtitling, transcription, and translation solutions, is excited to announce its presence at the IBC Show 2023, scheduled to take
A Curia apoia o ensaio clínico de fase 1 da nova vacina de RNA de última geração da Replicate Bioscience
O fornecimento de um fármaco fabricado segundo as normas de BPFa apoia o primeiro estudo clínico em seres humanos do novo RNA autorreplicante (srRNA) RBI-4000 ALBANY, N.Y., Sept. 13, 2023 (GLOBE NEWSWIRE) — A Curia, uma organização líder em pesquisa,
Curia Supports Replicate Bioscience’s Phase 1 Clinical Trial of Novel Next-Generation RNA Vaccine
Supply of drug substance manufactured under cGMP supports first-in-human clinical study for RBI-4000 novel self-replicating RNA (srRNA) ALBANY, N.Y., Sept. 13, 2023 (GLOBE NEWSWIRE) — Curia, a leading contract research, development and manufacturing organization, today announced that its partner, Replicate
Curia soutient l’essai clinique de phase 1 de Replicate Bioscience sur un vaccin novateur à base d’ARN de nouvelle génération
L’entreprise apporte une substance médicamenteuse fabriquée selon les BPFa afin de permettre la première étude clinique chez un être humain du nouvel ARN auto-répliquant (ARNar) RBI-4000 ALBANY, ÉTAT DE NEW YORK, 13 sept. 2023 (GLOBE NEWSWIRE) — Curia, une organisation
Annual Investment Meeting announces new identity as AIM Congress, gears up for 13th edition in Abu Dhabi, May 2024
ABU DHABI, United Arab Emirates, Sept. 13, 2023 (GLOBE NEWSWIRE) — Under its new identity as “AIM Congress,” the Organizing Committee of the World’s Leading Investment Platform will once again gather together regional and international leaders, thinkers, and innovators at